CA Stock MarketDetailed Quotes

DMT Small Pharma Inc

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayTrading Jul 26 09:30 ET
0Market Cap0.00P/E (TTM)

Small Pharma Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)May 31, 2023
(FY)Feb 28, 2023
(Q4)Feb 28, 2023
(Q3)Nov 30, 2022
(Q2)Aug 31, 2022
(Q1)May 31, 2022
(FY)Feb 28, 2022
(Q4)Feb 28, 2022
(Q3)Nov 30, 2021
(Q2)Aug 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
8.64%-5.76M
-36.81%-22.21M
11.10%-4.55M
-51.56%-5.36M
-89.71%-6M
-42.64%-6.3M
-282.08%-16.23M
-183.67%-5.12M
-188.55%-3.54M
-314.79%-3.16M
Net income from continuing operations
2.39%-5.64M
-2.56%-22.84M
50.46%-2.37M
-55.08%-7.18M
-65.46%-7.5M
30.44%-5.78M
-216.49%-22.27M
-35.89%-4.79M
-185.62%-4.63M
-203.25%-4.53M
Operating gains losses
-45.74%4.31K
-98.05%41.34K
-54.14%2.79K
172.07%28.2K
-43.74%2.41K
-99.62%7.94K
129.24%2.12M
-99.28%6.08K
-82.80%10.37K
--4.29K
Depreciation and amortization
1,404.15%85.53K
136.46%48.44K
480.36%31.36K
9.86%5.75K
14.37%5.65K
15.78%5.69K
233.54%20.49K
31.24%5.4K
--5.23K
--4.94K
Remuneration paid in stock
5.33%115.44K
68.87%1.19M
45.14%176.28K
68.98%268.03K
122.53%634.7K
-20.90%109.6K
15.47%703.85K
-53.26%121.45K
1,059.00%158.62K
--285.22K
Other non cashItems
--7.62K
-99.85%2.57K
----
----
----
----
245.59%1.68M
-100.18%-731
-101.43%-1.09K
--181
Change In working capital
49.13%-328.23K
-143.25%-655.47K
-418.52%-2.39M
64.91%1.53M
-20.38%855.46K
-2,748.93%-645.2K
98.65%1.52M
-319.89%-461.07K
277.23%924.75K
189.63%1.07M
-Change in receivables
-60.33%191.96K
145.86%350.25K
107.39%62.89K
-2,212.64%-87.97K
-138.43%-108.61K
352.29%483.94K
-209.57%-763.7K
-279.63%-850.67K
99.47%-3.8K
1,999.65%282.59K
-Change in prepaid assets
151.77%133.46K
113.78%117.46K
137.95%408.46K
8,910.64%219.39K
-1,060.14%-252.56K
-203.95%-257.82K
-226.15%-852.66K
-338.06%-1.08M
-117.06%-2.49K
-60.30%-21.77K
-Change in payables and accrued expense
24.98%-653.65K
-135.86%-1.12M
-295.23%-2.86M
49.68%1.39M
49.53%1.22M
-1,004.90%-871.32K
146.40%3.13M
8,179.93%1.47M
-1.73%931.04K
119.25%813.65K
Cash from discontinued investing activities
Operating cash flow
8.64%-5.76M
-36.81%-22.21M
11.10%-4.55M
-51.56%-5.36M
-89.71%-6M
-42.64%-6.3M
-282.08%-16.23M
-183.67%-5.12M
-188.55%-3.54M
-314.79%-3.16M
Investing cash flow
Cash flow from continuing investing activities
0
202.78%2.47M
-254.09%-15.98K
62.76%-2.41K
126,792.90%2.5M
99.55%-10.71K
-3,279.41%-2.4M
92.11%-4.51K
26.52%-6.47K
61.37%-1.97K
Capital expenditure reported
----
---10.85K
----
----
----
----
--0
----
----
----
Net PPE purchase and sale
--0
-43.57%-18.6K
-13.76%-5.13K
62.76%-2.41K
82.31%-349
---10.71K
81.78%-12.96K
92.11%-4.51K
---6.47K
---1.97K
Net business purchase and sale
----
--0
--0
--0
----
----
--109.15K
--0
--0
--0
Net other investing changes
----
200.00%2.5M
--0
--0
----
----
---2.5M
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
--0
202.78%2.47M
-254.09%-15.98K
62.76%-2.41K
126,792.90%2.5M
99.55%-10.71K
-3,279.41%-2.4M
92.11%-4.51K
26.52%-6.47K
61.37%-1.97K
Financing cash flow
Cash flow from continuing financing activities
-650.39%-83.42K
-100.81%-436.41K
-116.87%-13.24K
-281.36K
-997.00%-156.98K
-99.97%15.16K
472.84%53.89M
-98.77%78.45K
0
-98.94%17.5K
Net issuance payments of debt
---83.42K
---13.24K
----
----
----
--0
--0
----
----
----
Net common stock issuance
----
-100.90%-483.04K
--0
---281.36K
----
----
54,629.23%53.8M
--47.29K
--0
--0
Proceeds from stock option exercised by employees
--0
-34.46%59.87K
--0
--0
155.49%44.71K
-64.50%15.16K
--91.34K
--31.15K
--0
--17.5K
Cash from discontinued financing activities
Financing cash flow
-650.39%-83.42K
-100.81%-436.41K
-116.87%-13.24K
---281.36K
-997.00%-156.98K
-99.97%15.16K
472.84%53.89M
-98.77%78.45K
--0
-98.94%17.5K
Net cash flow
Beginning cash position
-54.41%18.54M
603.64%40.66M
-50.15%22.74M
-46.02%27.15M
-39.36%32M
603.64%40.66M
926.65%5.78M
5,143.67%45.62M
4,541.01%50.29M
25,999.06%52.77M
Current changes in cash
7.25%-5.84M
-157.24%-20.18M
9.22%-4.58M
-59.29%-5.64M
-16.20%-3.66M
-113.41%-6.3M
592.93%35.25M
-211.99%-5.04M
-6,374.31%-3.54M
-455.40%-3.15M
Effect of exchange rate changes
119.40%457.45K
-419.66%-1.94M
383.19%372.19K
210.55%1.24M
-281.41%-1.2M
-21,557.10%-2.36M
-392.56%-373.81K
-80.90%77.03K
-315.66%-1.12M
16,294.19%660.08K
End cash Position
-58.90%13.15M
-54.41%18.54M
-54.41%18.54M
-50.15%22.74M
-46.02%27.15M
-39.36%32M
603.64%40.66M
603.64%40.66M
5,143.67%45.62M
4,541.01%50.29M
Free cash from
8.80%-5.76M
-36.88%-22.24M
10.87%-4.57M
-51.35%-5.36M
-89.60%-6M
-42.88%-6.31M
-276.09%-16.25M
-175.19%-5.12M
-185.84%-3.54M
-315.05%-3.16M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)May 31, 2023(FY)Feb 28, 2023(Q4)Feb 28, 2023(Q3)Nov 30, 2022(Q2)Aug 31, 2022(Q1)May 31, 2022(FY)Feb 28, 2022(Q4)Feb 28, 2022(Q3)Nov 30, 2021(Q2)Aug 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 8.64%-5.76M-36.81%-22.21M11.10%-4.55M-51.56%-5.36M-89.71%-6M-42.64%-6.3M-282.08%-16.23M-183.67%-5.12M-188.55%-3.54M-314.79%-3.16M
Net income from continuing operations 2.39%-5.64M-2.56%-22.84M50.46%-2.37M-55.08%-7.18M-65.46%-7.5M30.44%-5.78M-216.49%-22.27M-35.89%-4.79M-185.62%-4.63M-203.25%-4.53M
Operating gains losses -45.74%4.31K-98.05%41.34K-54.14%2.79K172.07%28.2K-43.74%2.41K-99.62%7.94K129.24%2.12M-99.28%6.08K-82.80%10.37K--4.29K
Depreciation and amortization 1,404.15%85.53K136.46%48.44K480.36%31.36K9.86%5.75K14.37%5.65K15.78%5.69K233.54%20.49K31.24%5.4K--5.23K--4.94K
Remuneration paid in stock 5.33%115.44K68.87%1.19M45.14%176.28K68.98%268.03K122.53%634.7K-20.90%109.6K15.47%703.85K-53.26%121.45K1,059.00%158.62K--285.22K
Other non cashItems --7.62K-99.85%2.57K----------------245.59%1.68M-100.18%-731-101.43%-1.09K--181
Change In working capital 49.13%-328.23K-143.25%-655.47K-418.52%-2.39M64.91%1.53M-20.38%855.46K-2,748.93%-645.2K98.65%1.52M-319.89%-461.07K277.23%924.75K189.63%1.07M
-Change in receivables -60.33%191.96K145.86%350.25K107.39%62.89K-2,212.64%-87.97K-138.43%-108.61K352.29%483.94K-209.57%-763.7K-279.63%-850.67K99.47%-3.8K1,999.65%282.59K
-Change in prepaid assets 151.77%133.46K113.78%117.46K137.95%408.46K8,910.64%219.39K-1,060.14%-252.56K-203.95%-257.82K-226.15%-852.66K-338.06%-1.08M-117.06%-2.49K-60.30%-21.77K
-Change in payables and accrued expense 24.98%-653.65K-135.86%-1.12M-295.23%-2.86M49.68%1.39M49.53%1.22M-1,004.90%-871.32K146.40%3.13M8,179.93%1.47M-1.73%931.04K119.25%813.65K
Cash from discontinued investing activities
Operating cash flow 8.64%-5.76M-36.81%-22.21M11.10%-4.55M-51.56%-5.36M-89.71%-6M-42.64%-6.3M-282.08%-16.23M-183.67%-5.12M-188.55%-3.54M-314.79%-3.16M
Investing cash flow
Cash flow from continuing investing activities 0202.78%2.47M-254.09%-15.98K62.76%-2.41K126,792.90%2.5M99.55%-10.71K-3,279.41%-2.4M92.11%-4.51K26.52%-6.47K61.37%-1.97K
Capital expenditure reported -------10.85K------------------0------------
Net PPE purchase and sale --0-43.57%-18.6K-13.76%-5.13K62.76%-2.41K82.31%-349---10.71K81.78%-12.96K92.11%-4.51K---6.47K---1.97K
Net business purchase and sale ------0--0--0----------109.15K--0--0--0
Net other investing changes ----200.00%2.5M--0--0-----------2.5M--0--0--0
Cash from discontinued investing activities
Investing cash flow --0202.78%2.47M-254.09%-15.98K62.76%-2.41K126,792.90%2.5M99.55%-10.71K-3,279.41%-2.4M92.11%-4.51K26.52%-6.47K61.37%-1.97K
Financing cash flow
Cash flow from continuing financing activities -650.39%-83.42K-100.81%-436.41K-116.87%-13.24K-281.36K-997.00%-156.98K-99.97%15.16K472.84%53.89M-98.77%78.45K0-98.94%17.5K
Net issuance payments of debt ---83.42K---13.24K--------------0--0------------
Net common stock issuance -----100.90%-483.04K--0---281.36K--------54,629.23%53.8M--47.29K--0--0
Proceeds from stock option exercised by employees --0-34.46%59.87K--0--0155.49%44.71K-64.50%15.16K--91.34K--31.15K--0--17.5K
Cash from discontinued financing activities
Financing cash flow -650.39%-83.42K-100.81%-436.41K-116.87%-13.24K---281.36K-997.00%-156.98K-99.97%15.16K472.84%53.89M-98.77%78.45K--0-98.94%17.5K
Net cash flow
Beginning cash position -54.41%18.54M603.64%40.66M-50.15%22.74M-46.02%27.15M-39.36%32M603.64%40.66M926.65%5.78M5,143.67%45.62M4,541.01%50.29M25,999.06%52.77M
Current changes in cash 7.25%-5.84M-157.24%-20.18M9.22%-4.58M-59.29%-5.64M-16.20%-3.66M-113.41%-6.3M592.93%35.25M-211.99%-5.04M-6,374.31%-3.54M-455.40%-3.15M
Effect of exchange rate changes 119.40%457.45K-419.66%-1.94M383.19%372.19K210.55%1.24M-281.41%-1.2M-21,557.10%-2.36M-392.56%-373.81K-80.90%77.03K-315.66%-1.12M16,294.19%660.08K
End cash Position -58.90%13.15M-54.41%18.54M-54.41%18.54M-50.15%22.74M-46.02%27.15M-39.36%32M603.64%40.66M603.64%40.66M5,143.67%45.62M4,541.01%50.29M
Free cash from 8.80%-5.76M-36.88%-22.24M10.87%-4.57M-51.35%-5.36M-89.60%-6M-42.88%-6.31M-276.09%-16.25M-175.19%-5.12M-185.84%-3.54M-315.05%-3.16M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg